Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study. [electronic resource]
Producer: 20040527Description: 134-8 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Ambulatory Care
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- Humans
- Injections, Intravenous
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Stem Cell Transplantation
- Thalidomide -- administration & dosage
- Transplantation, Autologous
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.